Pasireotide (Signifor, Signifor LAR)

This is the fourth podcast in a series of five on medications to treat Cushing's disease.  Today Dr. Blevins discusses Pasireotide, trade names Signifor and Signifor LAR.

Isturisa® (osilodrostat)

Our third podcast in the series is on osilodrostat (trade name Isturisa®), a drug approved by the FDA in the US and the European Medicines Agency (EMA) to treat hypercortisolism in patients who are not candidates for surgery or those that surgery did not work.  In this podcast, Dr. BLevins takes us inside his clinical practice to share his experiences with the drug.


The second podcast in our series on the medical management of hypercortisolism focuses on the drug metyrapone. Dr. Blevins discusses the drug uses, how it works, and its side effects.  Coming up next, a discussion on the drug Isturiza® (osilodrostat).


This is the first in our series of five podcasts on the medical management of Hypercortisolism due to Cushing's disease. Today Dr. Blevins discusses the drug Ketoconazole. Tune in tomorrow to listen to the second podcast in the series on the use of Metyrapone, and on Monday, don't miss the podcast on Isturisa® (osilodrostat).

The challenges and opportunities in new hypercortisolism drugs

Today we welcome three renowned experts in the development of drugs to treat hypercortisolism. Dr. Blevins and I discuss their research, clinical trials, challenges, and opportunities for these essential medications that could immensely affect patient well-being and quality of life. This discussion touches on the fascinating details of hypercortisolism and the developments now and in the future.

Acromegaly: the last 30 years

In this Podcast, Dr. Blevins gives us a perspective of the last 30 years on the developments in this field. Like many other conditions, the advances in therapy, imaging, surgery techniques, diagnostic testing, and clinical knowledge have been nothing short of remarkable.

Podcast – Ride for acromegaly: 1,200 miles down; 680 miles to go.

Last week we caught up with Risa in San Francisco, California. She was nearing 1,200 miles (1,931 kilometers) on her bicycle ride from Canada...

The postoperative evaluation and management of patients with hypercortisolism

Dr. Lewis Blevins' discussion on the postoperative evaluation and management of patients with hypercortisolism is technical and directed to physicians, but we encourage everyone to listen to it. 

Critical insights on Diabetes Insipidus

PODCAST: Dr. Blevins takes an in-depth look at Diabetes Insipidus with a specific focus on diagnostic testing. In this podcast, you will be...

The frustrating process of insurance authorizations for the use of medicines

What happens when the insurance company's first line of response is to deny, deny, deny?  How does this increase in oversight from third-party payors...